Objective: The SH3-domain GRB2-like (endophilin)-interacting protein 1 (SGIP1) gene has been shown to be differentially expressed in the hypothalamus of lean versus obese Israeli sand rats (Psammomys obesus), and is suspected of having a role in regulating food intake. The purpose of this study was to assess the role of genetic variation in SGIP1 in human disease. Subjects: We performed single-nucleotide polymorphism (SNP) genotyping in a large family pedigree cohort from the island of Mauritius. The Mauritius Family Study (MFS) consists of 400 individuals from 24 Indo-Mauritian families recruited from the genetically homogeneous population of Mauritius. We measured markers of the metabolic syndrome, including diabetes and obesity-related phenotypes such as fasting plasma glucose, waist:hip ratio, body mass index and fat mass. Results: Statistical genetic analysis revealed associations between SGIP1 polymorphisms and fat mass (in kilograms) as measured by bioimpedance. SNP genotyping identified associations between several genetic variants and fat mass, with the strongest association for rs2146905 (P ¼ 4.7 Â 10 À5 ). A strong allelic effect was noted for several SNPs where fat mass was reduced by up to 9.4% for individuals homozygous for the minor allele. Conclusions: Our results show association between genetic variants in SGIP1 and fat mass. We provide evidence that variation in SGIP1 is a potentially important determinant of obesity-related traits in humans.
Introduction
The global prevalence of obesity has increased dramatically over the last 30 years and is predicted to increase further in the coming decades. The World Health Organisation (WHO) data estimate that at least 400 million adults were obese (body mass index (BMI) 430 kg m À2 ) in 2005, and the forecasted projection suggests that this figure will rise to more than 700 million by 2015. 1 Diabetes mellitus type 2 has become one of the most common chronic diseases worldwide, and the number of persons with diabetes is estimated to rise to 439 million adults by 2030. 2 The epidemic of obesity-associated diabetes is a major crisis in modern societies, in which food is plentiful and exercise is optional. The hypothalamus is a central regulator of energy balance integrating both central and peripheral signals. 3, 4 Defects in hypothalamic function can therefore lead to obesity and diabetes. A number of candidate genes that have been robustly replicated for obesity and related traits include the melanocortin 4 receptor (MC4R), the adrenergic b3 receptor (ADRB3), prohormone convertase 1/3 (PCSK1), brain-derived neurotropic factor (BDNF) and the endocannabinoid receptor 1 (CNR1). [5] [6] [7] [8] [9] Functional studies show that they contribute to obesity through a variety of mechanisms, including regulation of food intake, regulation of lipolysis, thermogenesis and effects on hyperactivity. Genome-wide scans for obesity phenotypes have led to the identification of several chromosome regions that are likely to harbor obesitysusceptibility genes. [10] [11] [12] Owing to the increasing number of genome scans, several regions of replication have emerged, including 16q12, 10p13 and 16q23. 13 Identification of causative genetic mutations in these linked regions will likely unveil new insights into the molecular and pathophysiological mechanisms of energy homeostasis and obesity. We have previously described Psammomys obesus (Israeli sand rat) as a polygenic animal model of obesity, type 2 diabetes and dyslipidemia. [14] [15] [16] [17] This model has been used to identify genes and metabolic pathways that influence the development of metabolic syndrome and have demonstrated associations with these traits in large human cohorts including ubiquitin-like 5 (refs 18,19) and selenoprotein S. 20 SH3-domain GRB2-like (endophilin)-interacting protein 1 (SGIP1) was first discovered by differential display PCR analysis of hypothalamus RNA from lean and obese P. obesus and was found to be exclusively expressed in the central nervous system. 16 SGIP1 expression was increased in the hypothalamus of obese P. obesus and the encoded 828 amino-acid protein colocalized with POMC and NPY, two neuropeptides involved in the regulation of energy balance. Targeted reduction of hypothalamic SGIP1 mRNA by infusion of antisense oligonucleotides inhibited food intake and decreased body weight in P. obesus. SGIP1 mRNA expression was also elevated in the hypothalamus of Agouti mice, suggesting a role for this gene in the melanocortin signaling pathway. 16 SGIP1 is an endocytic protein that has a functional role in neuronal systems in energy homeostasis by interacting with endophilins. 16, 21 The human homolog of SGIP1 is located on chromosome 1p31.3. Genetic linkage studies have reported this region is likely to contain genes influencing obesity phenotypes. 22 The functional information obtained from the P. obesus studies, along with the genomic location of the human SGIP1 gene, make this gene a candidate gene for regulating energy balance and potentially important in determining obesity risk in humans. To address this possibility, 78 singlenucleotide polymorphisms (SNPs) were selected from NCBI's dbSNP database within the SGIP1 gene. These were genotyped in 400 Indo-Mauritians spanning 24 families and tested for association with metabolic syndrome phenotypes.
Subjects and methods

Subjects and phenotypes
The Mauritian Family Study consists of a cohort of 400 individuals in 24 large extended pedigrees. 23 The project was submitted to and approved by two independent ethics committees in both Australia, the sponsoring country, and Mauritius, the host country, according to the Council for International Organizations of Medical Sciences and WHO guidelines for International Biomedical Research Involving Human Subjects (Geneva 1993). Participation in the study was allowed after informed consent was obtained, following an explanation by local community health workers in their native language.
Phenotypes related to the metabolic syndrome were obtained from each individual during the course of a medical examination (Table 1) . Four phenotypes directly related to obesity, and body composition were assessed in the Mauritian cohort. These included waist/hip ratio, BMI and fat mass (in kilograms). BMI was calculated as weight in kilograms divided by height in meters squared. The waist measures were taken at the midpoint between the iliac crest and the lower rib margin, whereas the hip measurement was taken around the maximum circumference of the buttocks posteriorly and the symphisis pubis anteriorly. Waist and hip circumferences were measured in duplicate to the nearest 0.5 cm with a measuring tape while the participant was standing relaxed and wearing a single layer of light clothing. Body composition measures were taken using a singlefrequency bioelectrical impedance meter (BIM4 UniQuest Ltd, St Lucia, Australia), with the participants rested and lying horizontally on a bed. Total cholesterol and triglycerides were determined on fasting plasma by manual enzymatic methods. To measure aspects of glucose metabolism, we obtained fasting levels of insulin using a standard ELISA methods (DAKO, Eli, UK) and measures of plasma glucose using a YSI Glucose Analyser (Yellow Springs, OH). All plasma SH3-domain GRB2-like (endophilin)-interacting protein 1 N Cummings et al measures were done in duplicate, and quality control procedures were implemented to maintain accuracy across batches.
SNP selection and genotyping
A total of 78 SNPs were chosen from NCBIs dbSNP database. SNPs were selected on the basis of their likelihood to have a functional role. Therefore, selection focused on those in exonic, putative promoter, splice sites and conserved sequence (between mouse and human), whereas non-conserved and repetitive regions were avoided. Genotyping was carried out using the MassARRAY system (Sequenom, San Diego, CA, USA) as per the manufacturer's standard protocols. Primers were designed to amplify B100 bp surrounding the variant sites. PCR amplification was performed using 10 ng of genomic DNA following standard reaction conditions in a total volume of 5 ml.
Allele frequency estimation
Maximum likelihood techniques that account for pedigree structure were used to estimate allele frequencies for SGIP1.
Estimates obtained using samples containing related individuals can be significantly biased unless pedigree structure is taken into account. 24 The estimates of allele frequencies and their standard errors were obtained using SOLAR. 25 Similarly, SOLAR was used to perform tests of Hardy-Weinberg equilibrium allowing for non-independence among pedigree members. Any SNPs not within Hardy-Weinberg equilibrium were removed from analysis.
Measured genotype association analysis
The association model that we have used represents a simple extension of the classical variance component model described elsewhere. 26, 27 Estimation of the various fixed effects and variance components associated with the random effects can be performed using standard maximum likelihood methods. Note that this approach takes into account non-independence among family members. All analyses were performed using the computer package, SOLAR.
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To eliminate the potential for hidden population stratification that the standard fixed effect association approach is susceptible to, we also utilized the quantitative transmission disequilibrium test approach to association testing developed by Abecasis et al. 28 and implemented in SOLAR.
Although this approach exhibits substantially decreased power compared with measured genotype analysis, 29 it maintains the appropriate significance levels under the null hypothesis even in the presence of population stratification. However, because of its poor power, we utilize it only as a check to identify consistency of qualitative inferences drawn from measured genotype analysis.
Correction for multiple testing
To correct for the effect of multiple testing for a given phenotype, we estimated the effective number of SNPs using the method of Li and Ji 30 that employs a modification of an earlier approach by Nyholt. 31 After obtaining the effective number of independent SNPs, we used a modified Bonferroni procedure to identify a target alpha level that would maintain an overall significance level of o0.05.
Results
Genotyping of SNPs within the candidate gene SGIP1
A total of 78 SNPs were selected in SGIP1 for genotyping based on relative position of the variant to the structure of the gene; hence, their potential for conferring a functional consequence. SNPs in all coding exons and putative promoter/enhancer regions up to 150 bp from the transcription start site were included. Additionally, SNPs in the 3 0 UTR region that may affect mRNA stability and transport and contain target motifs of microRNA were included. From the 78 SNPs genotyped, 47 were found to be polymorphic in the founder population (n ¼ 92), This result is expected, as previous studies have shown that NCBI and HapMap datasets are skewed toward European and Asian populations, which do not reflect the ethnic background of Mauritius. 32 All 47 polymorphic SNPs were genotyped in the MFS cohort (n ¼ 400). Figure 1 shows the overall pattern of linkage disequilibrium (LD) measured by the absolute correlation (r) of polymorphic SNPs in SGIP1 that were associated with fat mass at P ¼ 0.05 or less. The LD pattern appears to be mostly random. Based on the evaluation of the Eigenstructure of the correlation matrix, 33 the effective number of independent 
SH3-domain GRB2-like (endophilin)-interacting protein 1 N Cummings et al
SNPs was 21.8. Thus, these 47 markers behave statistically like 22 independent markers. Heritability of fat mass was calculated at 0.32 (P ¼ 1.6 Â 10
À5
) in the MFS cohort. 23 Robust Bayesian quantitative nucleotide analysis was performed to assess possible associations between SGIP1 variants and obesity-related phenotypes. Each SNP was tested for association with a variety of phenotypic traits using the SOLAR statistical package. 25 Raw data was not normally distributed; hence, the data was normalized using inverse normal distribution and adjusted for age and sex. Of the phenotypes tested, four SNPs showed strong association with fat mass ( Table 2 ). The SNP rs2146905 showed the strongest association with fat mass (P ¼ 4.7 Â 10
), followed by rs1325266 (P ¼ 1.2 Â 10 À4 ), rs1900105 (P ¼ 5.8 Â 10
À4
) and rs4655650 (P ¼ 1.5 Â 10
À3
). These associations remained significant after multiple testing with a target alpha set at 0.002 on the basis of 22 independent SNPs. In all, 15 other SNPs showed nominal association with fat mass, with P-values ranging from 0.0022 to 0.0459 (Table 2 ). It should be noted that rs2146905 and rs1325266 are in high LD (D 0 ¼ 0.994) with each other (Figure 1 ). The SNP most strongly associated with fat mass (rs2146905) showed a nominal association with BMI (P ¼ 0.037) as did rs7529763 (P ¼ 0.044). None of the SNPs associated with fat mass showed an association with waist:hip ratio.
Notable allelic effects are observed for SNPs associated with fat mass (Table 2 ). For the most strongly associated SNP (rs2146905), there was a 5.7% reduction in fat mass in individuals homozygous for the minor allele compared with individuals homozygous for the major allele. For one nominally significant SNP (rs4142763), there was a 9.4% reduction in fat mass in individuals homozygous for the minor allele compared with individuals homozygous for the major allele. In all cases, the allelic effect was additive, whereby heterozygous individuals had a fat mass value in the mid-range between homozygous individuals with major or minor alleles.
Discussion
A number of SNPs in SGIP1 showed evidence of association with fat mass in the Mauritian Family Study cohort. The effect of allelic variants on fat mass ranged from þ 4.5 to À9.4%, with P-values ranging from 0.0459 to 4.7 Â 10 À5 .
The SH3-domain GRB2-like (endophilin)-interacting protein 1 (SGIP1) gene was identified as differentially expressed in the hypothalamus of lean versus obese P. obesus, an animal model of type 2 diabetes and obesity. Further studies demonstrated that SGIP1 has a role in regulating food intake, where targeted reduction of hypothalamic SGIP1 mRNA inhibited food intake and decreased body weight in both P. obesus and Sprague-Dawley rats. 16 As markers of the metabolic syndrome, we measured several diabetes/obesity-related phenotypes, including fasting plasma glucose, waist:hip ratio, BMI and fat mass. We genotyped 47 polymorphic SNPs in SGIP1 selected for the potential to confer a functional effect on the gene. Statistical genetic analysis revealed associations between 19 SNPs in SGIP1 and fat mass as measured by bioimpedance. Four of these SNPs were strongly associated with fat mass after adjustment for multiple testing, and a further 15 SNPs were nominally associated with fat mass. 
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The SNP rs2146905 showed the strongest association with fat mass (P ¼ 4.7 Â 10
À5
). In individuals homozygous for the minor allele, there was a 5.7% reduction in fat mass compared with individuals homozygous for the major allele (minor allele frequency ¼ 0.39). Although this SNP is located in intron 7 of SGIP1, it may be in high LD with SNPs located in regions that regulate transcription or affect mRNA stability.
We observed a strong allelic effect for several SNPs associated with fat mass in SGIP1. Individuals homozygous from the major allele had changes ranging from þ 4.5 to À9.4% compared with individuals homozygous for the major allele. One nominally significant SNP, rs485521, showed a reduction in fat mass of 4.5% for individuals homozygous for the minor allele. This SNP is located in the 3 0 UTR and may affect mRNA stability, microRNA binding and expression of SGIP1. Another nominally significant SNP, rs4142763, showed a reduction in fat mass of 9.4% for individuals homozygous for the minor allele. This SNP is located in the 5 0 UTR and may affect SGIP1 gene function by altering transcription. Of the 19 SNPs associated with fat mass, 5 showed reduced fat mass for individuals homozygous for the major allele, whereas 14 showed reduced fat mass for individuals homozygous for the minor allele. Minor allele frequencies ranged from 0.03 to 0.50 (Table 2) .
Only 1 of the 19 SNPs associated with fat mass, rs7526812, was located within a coding region (exon 7) and created a missense mutation. The four most strongly associated SNPs were located in introns 3, 6 and 8. It remains unclear how these variants influence SGIP1 activity or whether they are in LD with more distant, or exon-based variants that influence SGIP1 activity, but these may affect expression through enhancer elements or be in LD with coding SNPs or those that affect expression levels.
Previous studies in animal models have shown a physiological role for SGIP1 in hypothalamic neuronal systems that promote positive energy balance and weight gain. Furthermore, depletion of hypothalamic SGIP1 mRNA reduced body weight by inducing an inappropriately high metabolic rate. 16 Whether genetic variation in the SGIP1 gene acts to alter SGIP1 protein expression remains to be seen and is an important question for future experiments. This study describes an association between genetics variants in the SGIP1 gene and fat mass in the Mauritian population. This evidence, combined with functional data from previous studies, strongly suggests that variation in SGIP1 is a potentially important new determinant of obesity-related traits.
